INTRODUCTION
The existence of autonomous protein synthesis in the mitochondria of eukaryotic cells has been well established (1, 2) . The mitochondrial protein synthesis system has been characterized in unicellular organisms such as yeast, Neurospora, . More recently, the protein synthesis system of mammalian mitochondria has been partially characterized (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . The active unit of this system appears to be a 55S (20) particle which occurs assembled into 95S structures (18) . In mammalian cells this system produces a small number of polypeptides, perhaps six or seven (21) .
Several specific inhibitors of mitochondrial-spe-THE JOURNAL OF CELL BIOLOGY . VOLUME 49, 1971 . pages 541-546 cific RNA and protein syntheses are available . Ethidium bromide inhibits mitochondrial RNA synthesis at very low concentrations . The drug has little effect on the synthesis of RNA occurring outside of mitochondria (22) . It also inhibits mitochondria) DNA replication' and rapidly reduces mitochondrial protein synthesis to immeasurable levels (19) . Chloramphenicol is a specific and complete inhibitor of mitochondrial protein synthesis but has little effect on other cellular synthetic processes (11, 18, 19, 23, 24) . HeLa cells in suspension culture continue to I Leibowitz, R. Manuscript in preparation .
grow for two generations in the presence of concentrations of ethidium bromide or chloramphenicol which almost completely inhibit mitochondrial protein synthesis (90%0) . The effects of such growth on mitochondrial structure and cell morphology have been examined .
MATERIAL AND METHODS
HeLa cells were grown in suspension culture as previously described . Ethidium bromide was present in the medium at a concentration of 0 .5 yg/ml, or chloramphenicol at 50 µg/ml . The cells were diluted every day and the cell concentration never exceeded 4 X 10 5 cells/ml . Several fixation methods were employed, but the most satisfactory results were obtained from the following . Cells were collected by centrifugation at a speed of 800 rpm for 10 min in an International Pr-2 centrifuge (International Equipment Co ., Needham Heights, Mass .) higher speeds yielded disrupted cells . The cell pellets were washed by resuspension in Earle's saline (25) and collected again . The pellets were then fixed for 1 hr in 2 .5% glutaraldehyde buffered with 0 .1 M cacodylic acid, and then were washed for 2 hr in 0.2 M sucrose buffered with cacodylate (26) . Postfixation with 2% osmium tetroxide buffered with sodium barbital (27) was followed with a 30 min wash in 0 .5% uranyl acetate (28, 29) . The pellets were dehydrated in ethanol and washed for 15 min in propylene oxide (30) . A mixture of two parts Epon B to one part Epon A (30) was introduced to the pellets through graded concentrations of propylene oxide . The pellets were then embedded in this same Epon mixture . Thin sections were cut on a Sorvall Porter-Blum ultramicrotome MT-2 and stained with 0 .5% uranyl acetate (31) for 2 .5 min, followed by lead citrate (32) for 2 min . Electron micrographs were taken with a Siemens Elmiskop I.
RESULTS
HeLa cells growing in suspension culture show a well-defined and reproducible growth response to either of the two agents used here . The cell generation time rises from 24 hr to greater than 48 hr . The cell number always increases by a factor of four after 4 days of incubation. After this time, growth ceases and obvious cellular disintegration sets in . Fig. 1 shows the growth of control and ethidium bromide-treated cells . Cells grow more slowly in the presence of the inhibitor but the population does eventually increase by a factor of four . Both light microscopy and electron microscopy indicate that the drug-treated cells are about the same size as control cells, indicating an increase in cell mass 542 BRIEF NOTES as well as number . Essentially the same growth curve is obtained with chloramphenicol . Fig . 2 shows a typical section from control cells which have been stained so as to accentuate the cristae of the mitochondria . The mitochondria resemble those previously described by other investigators (33, 34) . This figure may be compared to Fig. 3 which shows a section from cells incubated for 3 days in chloramphenicol. The effect on the cristae of mitochondria is quite dramatic ; there are many fewer mitochondrial cristae than in control cells . A similar result has been obtained previously with the mitochondria from yeast treated with chloramphenicol (24) . The inner mitochondrial membrane appears to have a drasti- FIGURE 3 Cells incubated 3 days in chloramphenicol . Note distorted inner mitochondrial membrane and relatively scarce cristae . CM, circular inner mitochondrial membrane ; Vac, vacuoles presumably containing lipids ; Go, Golgi-like lamellar structure ; D, dark-staining bodies . X 48,000.
cally altered organization and it no longer forms the folds or cristae characteristic of normal mitochondria . Especially interesting is the occurrence of circular inner membranes where the structures have apparently broken loose from much of the outer mitochondrial membrane . These circular membranes are characteristic of drug-treated cells and are not seen in control cells .
The inhibition of mitochondrial-specific macromolecular metabolism eventually has significant effects on the morphology of the cell cytoplasm . Droplets apparently containing lipids appear scattered through the cytoplasm of the drug-treated cells shown in Fig. 3 . These droplets are rarely seen in control cells . Also, after this long period of treatment, numerous dark-staining objects of unknown significance are found . While these objects occur within 1 day after drug treatment, they increase in number until cell growth stops .
Since cell mass has increased by a factor of four, it is possible to ask whether mitochondrial mass has been diluted by this factor . A qualitative estimate of the number of mitochondria and the contour length of the outer membrane indicates that, in fact, the mitochondrial mass is approximately the same in control and drug-treated cells. Thus the formation of organelles identifiable as mitochondria apparently does not depend upon mitochondrial-specific protein synthesis .
DISCUSSION
The amount of genetic information contained in the mammalian mitochondrial genome is limited and appears to code for only a few different polypeptides (21 ; S. Penman, unpublished) . Most of the mitochondrial-specific enzymes must therefore be synthesized in the cell cytoplasm under the direction of nuclear genes . Preliminary results in this and other laboratories indicate that the synthesis of some mitochondrial-specific enzymes apparently ceases in the cell after the administration of either ethidium bromide or chloramphenicol . Presumably, the proteins synthesized in the mitochondria are necessary for the continued production or stabilization of mitochondrial proteins which are synthesized outside of the mitochondria . As the cells grow in the presence of the drug, mitochondrial activities such as cytochrome oxidase are gradually diluted out .
It appears that, despite the inhibition of formation of normal mitochondrial structure in the presence of the two inhibitors studied here, cells continue to grow for a limited time, presumably by using the pre-existing mitochondrial proteins . An increase in cell mass by a factor of four, however, appears to exhaust this pre-existing capacity and cells thereafter enter a phase of rapid degradation .
These results suggest that the outer mitochondrial membrane can be formed in the absence of mitochondrial-specific protein synthesis since cells grown in the presence of the inhibitors appear to have an approximately normal complement of mitochondrial-like bodies with about the same surface area as in control cells . The inner mitochondrial membrane behaves quite differently. Both inhibitors cause its gradual disappearance . The inner mitochondrial membrane which remains is quite aberrant in form, and the infolding into the shape of cristae rapidly disappears . The mitochondrial protein-synthesizing system may produce some crucial proteins of the inner mitochondrial membrane or proteins necessary to correctly anchor the inner mitochondrial membrane to the outer membrane .
The appearance of lipid droplets in cells exposed to mitochondrial-specific inhibitors may reflect an interference with the fatty acid metabolism carried out by mitochondria . However, such droplets appear to be generally characteristic of pathologic states in cells and their appearance may not be a direct consequence of aberrant mitochondrial function . The appearance of Golgi-like lamellar structures, while difficult to quantitate, is a striking response to the inhibitors . Finally, the densely staining bodies observed in the cells constitute a type of structure whose origin and significance is unknown .
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